A5001054131- Mental Health and Patient Involvement
- Health Policy Implementation Science
- Social Media in Health Education
- Health Sciences Research and Education
- Health and Medical Research Impacts
- Health Systems, Economic Evaluations, Quality of Life
- Herpesvirus Infections and Treatments
- Dental Education, Practice, Research
- Pharmacological Effects of Natural Compounds
- Healthcare innovation and challenges
- Empathy and Medical Education
- Autoimmune and Inflammatory Disorders Research
- Pharmaceutical studies and practices
- Toxin Mechanisms and Immunotoxins
- Adolescent and Pediatric Healthcare
- Patient-Provider Communication in Healthcare
- Medication Adherence and Compliance
- Acute Lymphoblastic Leukemia research
Pfizer (United Kingdom)
2021-2025
Pfizer (United States)
2024
This study aimed to (1) gauge patients understanding and expectations of real-world data evidence (RWDE) research (2) use this lived experience co-create resources a framework for embedding meaningful patient public involvement engagement (PPIE) in RWDE within the pharmaceutical industry setting. An academic organisation, company PPIE panel 12 or carers partnered form project team. The was purposively selected maximise diversity. Participatory co-design methods were used engender an...
Juvenile idiopathic arthritis (JIA) is a heterogeneous disease, the signs and symptoms of which can be summarised with use composite disease activity measures, including clinical Arthritis Disease Activity Score (cJADAS). However, clusters children young people might experience different global patterns in their run parallel or diverge over time. We aimed to identify such 3 years after diagnosis JIA. The identification these would allow for greater understanding progression JIA, how...
The use of oral anticancer medications has become more prevalent in cancer therapy. This is particularly the case management advanced non-small cell lung (NSCLC). However, when treatment delivery interaction between patient and healthcare provider removed, risk non-adherence increases. Insights into preferences can allow drug product formulation scientists to design patient-centric that may promote an increase adherence which, turn, lead beneficial health outcomes.